200 results about "Post prandial blood glucose" patented technology

A method and system for optimizing post prandial blood glucose excursions for persons with diabetes via computation of time-varying optimal insulin profiles are disclosed. The method builds upon a mathematical model based on the physiologic description of the human glucoregulatory system. Model parameter values are specific for each patient and meal type, and are determined from measured data by minimizing differences between both measurements and model predictions, and which are used to provide the optimal insulin profiles that are useful to diabetics in managing their chronic disease.

Disclosed is a method for managing obesity, diabetes, hair loss, aging, cardiovascular, or other blood glucose-spike-induced diseases by reducing the post-prandial blood glucose spike, or the glucose shock. The blood glucose spike, or the glucose shock is reduced by generating a person-specific glucose profile for at least one significant meal to tune or train a blood glucose model (kinetic, artificial intelligence or hybrid), and then using the tuned or the trained model embedded in a computation-capable electronic device to compute and recommend a person-specific meal plan and an exercise plan, including semi-continuous meal ingestion and post-meal exercise while sitting at home or office. Advantages over prior art are that the method uses less strenuous exercise with no or less medicine, is person-specific, quantitative and more suitable for use by an individual, a dietician, or a health care practitioner.

Described are a number of compositions, namely a konjac mannan mixture, a ginseng composition, and a composition comprising konjac mannan and American ginseng. Methods of use of these compositions are described including their use for reducing blood glucose in non-diabetic and diabetic individuals, as well as reducing postprandial blood glucose in such individuals. Applications in the treatment of hyperlipidemia, high blood pressure, an increase in nitric oxide, Syndrome X and cardiovascular disease are also described. Various other applications of the compositions and methods are also described.

Described is use of Salvia hispanica L. (Chia) for controlling, in one embodiment reducing, blood glucose levels, preferably post-prandial blood glucose levels. This is useful in both non-diabetic and diabetic individuals, but especially in diabetic individuals. Also described is the use of chia in reducing postprandial blood glucose, insulin sensitivity, blood pressure, and oxidative stress in such individuals. The present invention further found that Chia can be used to improve endothelial function, coagulation, fibrinolysis and iron status. The present invention further encompasses the use of Chia in the treatment and / or management of diabetes and / or the treatment and management of diabetes associated conditions or risk factors, such as one or more of the following: blood pressure and blood glucose levels, post-prandial glycemia, inflammatory factors (C-reactive protein), coagulation (fibrinogen, factor VIII, von Willenbrand factor), and fibronolytic factors (such as t-PA), iron status and endothelial function, (such as increase in nitric oxide generation). In one embodiment the invention relates to dietary approaches to such treatment and management.

The present invention relates to a health care product, in particular to a post meal glucose-stabilized convenient nutrition conjee and the preparation method thereof, which can stabilize the blood glucose after meal. The present invention provides a convenient nutrition conjee which can stabilized the blood glucose after meal, wherein the brown rice and buckwheat rice in the prescription keep the nutritious elements and the fibers to the largest extent, while the rutin and chlorophyll contained in the buckwheat rice is what the other corn corps lack, and the minerals and the vitamins of the buckwheat rice are also higher than the level of the other crops, wherein based on the medical research, the flavone of the buckwheat rice has multiple functions of anti-oxidation, decrease blood glucose, and decrease blood lipid. The post meal glucose-stabilized convenient nutrition conjee provided by the present invention can balance the nutrition, act against oxidization, meliorate the insulin resistance, decrease the dosage of the glucose-lowering drugs, improve the insulin utilization rate of the patient, effectively improve the level of oral glucose tolerance test (OGTT) and the level of glycated haemoglobin (HbALC), improve the quality of life of the patient, prevent from the complications, and be in favor of the intake by the diabetes patient.

The invention discloses a use of lactobacillus plantarum ST-III in preparation of an alpha-glucosidase inhibitor or the preparation of a fermented bean product with alpha-glucosidase inhibition activity. The invention further discloses fermented soymilk or fermented beans with the alpha-glucosidase inhibition activity, which can be obtained by inoculating the lactobacillus plantarum ST-III into sterile soymilk or cooked soymilk and fermenting at the temperature of 25-40 DEG C. Water is added into the fermented beans for homogenizing, the pH value is regulated to 6.5-7.5, the boiling is performed for 10-60 minutes, cooling is performed, then solid-liquid separation is performed, and a liquid phase is taken so as to get a water-soluble extract of the fermented soymilk. The lactobacillus plantarum ST-III has high alpha-glucosidase inhibition activity and can be used in glucose-reducing foods, health care products or medicaments. As the oral glucose-reducing foods, the health care products or the medicaments, the high postprandial blood glucose of patients with diabetes can be reduced and the postprandial blood glucose fluctuation can be regulated.

The invention relates to a biscuit with the function of curing the diabetes and a preparation method thereof. The preparation method of the biscuit comprises the steps of: taking fingered citron, Chinese yam, mulberry, medlar, semen coicis, sealwort, fructus citri and kudzu root as raw materials; mixing the components of the raw materials; decocting extracting solution by means of water adding, and respectively filtering by a sieve with 160-180 meshes; concentrating filter liquor to obtain extractum; modulating flourdough according to the weight ratio of the extractum to the flour at 1:8-15; and preparing the biscuit by an existing normal biscuit preparation process. After the biscuit is eaten, the pancreas islet cell can be nourished, the pancreas islet function can be improved, the glucogenic index of the food can be effectively controlled, the fasting blood-glucose and the postmeal glucose can be reduced, the use level of the drug for curing the diabetes can be reduced, and the life quality can be improved.

The invention relates to a diet extender capable of restraining a diabetic's blood sugar level from rising after a meal. The diet extender comprises the following components by the weight percentage: 8-97 wt percent of indigestion carbohydrate, 1-10 wt percent of food gum, 1-90 wt percent of saccharide with low blood sugar level generation index, and 1-80 wt percent of flavoring agent. The diet extender capable of restraining the diabetic's blood sugar level from rising after the meal adopts water-soluble dietary fibers and the saccharide with the low blood sugar level generation index as raw materials, and ensures that the metabolism of the diet extender doest not depend on insulin, satiety cannot be increased excessively, normal diet cannot be affected, a diabetic can change a food habit of eating frequently but small meals, and enough energy and microelement are obtained from foods on the basis that the blood sugar level is restrained from rising.

The invention relates to a pharmaceutical composition having alpha-glucosidase inhibition activity, wherein the pharmaceutical composition comprises a flavone compound and an alpha-glucosidase inhibitor, the flavone compound is at least one selected from a monomer such as baicalein, quercetin, luteolin, baicalein-7-O-glucoside and catechin, an organic salt of the monomer, and an inorganic salt of the monomer, and the alpha-glucosidase inhibitor is at least one selected from a monomer such as acarbose, voglibose and miglitol, an organic salt of the monomer, and an inorganic salt of the monomer. According to the present invention, the pharmaceutical composition can effectively reduce postprandial blood glucose, can inhibit the activity of alpha-glucosidase adopting starch, maltose and sucrose as substrates, and less uses the alpha-glucosidase inhibitor, such that the efficacy can be improved, the side effect of the alpha-glucosidase inhibitor can be effectively reduced, and hypoglycemia and other problems easily caused by drug combination are effectively solved.

The invention discloses glucose-control porridge and belongs to the field of food. A formula of the porridge comprises that main ingredients and auxiliary ingredients are added into water per 1L, wherein the main ingredients comprise oat, buckwheat, brown rice, corn grits, pearl barley, peanuts, ormosia and kidney beans; and the auxiliary ingredients comprise functional dietary fibers such as Arabic gum and resistant starch, emulsifying agents such as sucrose ester, sodium tripolyphosphate and sodium pyrophosphate, a preservative such as sodium erythorbate, a sweetening agent such as acesulfame potassium and a flavor enhancer such as ethyl maltol. A preparation technology comprises the steps as follows: the main ingredients are washed clean, the peanuts, the ormosia and the kidney beans in the main ingredients are added into water in proportion and cooked for 10min by big fire in advance; other main ingredients are added and cooked for 10min by the big fire; the auxiliary ingredients are added sequentially and cooked for 30min in a 110-DEG C high-pressure sterilization pot; and the porridge is tinned and sealed. According to the glucose-control porridge, dissolution and absorption of glucose in the porridge can be reduced remarkably, so that rising of blood glucose after dining can be reduced remarkably. The porridge tastes good and is more complete in nutrition for diabetics and stronger in health-care function; and the defects that glucose-control products often taste hard, are inconvenient to eat and the like are overcome.

The invention relates to health food capable of lowering decomposition and absorption speeds of starch in bodies and a preparation method thereof. The preparation method is characterized by comprising the steps of adding vegetable powder to normal starch or a starch composition with different digestion rates and preparing starch particles through inclusion for granulation and drying. The health food has the characteristics that as the vegetable powder is added to the starch and serves as a skeleton, not only is the health food abundant in nutrients, but also slow release skeleton powder or particles can be formed, so that decomposition and absorption of the starch is slowed down and the blood glucose can not rise sharply and is in a steady state after people eats the health food; therefore, the postprandial blood glucose is lowered, the probability of various complications caused by blood glucose fluctuation after eating is lowered, and the quality of life of patients with diabetes mellitus is improved.

The invention relates to a technique for reducing in-vivo decomposition and release speed of starch, which is characterized by comprising the following steps: pulverizing starch food raw materials into fine powder or directly using starch,, adding a thickener and water, stirring uniformly to form a soft material, putting in a double screw extruder, extruding with a mold to obtain granules, and drying for later use; or drying the soft material, and pulverizing into fine powder for later use. The technique is characterized in that the edible thickener is added into the starch to reconstruct the physical structure of the starch granules, so that the starch decomposition is retarded, and the blood sugar after eating can not increase rapidly but is in a stable state, thereby lowering the postprandial blood sugar, lowering various complications initiated by blood sugar fluctuations after eating, and enhancing the life quality of diabetics.

The invention provides Rhizome Anemarrhenae use of medicine preparation for treating or preventing diabetes mellitus. Specifically, the Rhizome Anemarrhenae inhibits Alpha-glucosidase, reduces the blood sugar after dinner, promotes the glucose metabolism, balances the blood sugar, reduces the blood fat, advances the insulin secretion and keeps the blood sugar stability.

Compounds of formula I are disclosed which are useful as glycemic index lowering agents and / or, as α-amylase and / or α-glucosidase inhibitors. Also disclosed are nutritional and / or pharmaceutical compositions and supplements comprising one or more of these compounds. The compounds will be beneficial to patients who require stabilization of their postprandial glucose levels.

The invention relates to a technology for reducing in-vivo decomposition and absorption speeds of starch. The technology is characterized by comprising the following steps: crushing starch food raw materials into fine powder or directly utilizing the starch; adding a plant extract and preparing into a soft material by suitable amount of water; then putting the soft material into a double-screw extruder, and extruding into grains by a mould; drying for future use; or after drying the soft material, crushing the soft material into fine powder for future use. The technology has the innovations that the plant extract with an alpha-glucosaccharase inhibition effect is added into the starch so that the deposition and the absorption of the starch slow down; after the starch is eaten, the blood glucose is not suddenly raised and is at a balanced state, so that the postprandial blood glucose is reduced, various complications caused by blood glucose fluctuation after the starch is eaten are reduced and the living quality of diabetics is improved.

The invention discloses half-dried noodles special for diabetics and a making method of the half-dried noodles. According to the half-dried noodles, wheat flour, tartarian buckwheat flour, common buckwheat flour, wheat bran flour, dietary fiber powder, wheat gluten and the like are used as main materials, and sorbitol fluid, water and the like are used as auxiliary materials. The making method comprises the following steps of premixing the main materials according to a set ratio, and after the main materials are uniformly mixed, performing dynamic ozone circulation fumigation and steaming treatment; then placing the treated materials into a vacuum dough kneading machine, then adding the auxiliary materials and sterile water according to the proportion, and performing vacuum dough kneading; and then sequentially calendering flocculated dough, performing ageing, performing secondary calendering, performing cutting into strips, performing moderate dehydration, and performing tempering. The dietary fiber content of the half-dried noodle products disclosed by the invention is higher than 6%, so that the postprandial blood sugar level of the diabetes can be effectively controlled; and besides, the products are stable in quality, chewy and smooth in mouth feel and long in shelf life, the quality guarantee period of the products at room temperature reaches 3 months, and the quality guarantee period of the products under cold storage environment reaches 6 months.

The invention provides a method for preparing energy sustained-release sucked jelly with a function of controlling postprandial blood sugar. The sucked jelly is prepared from hydrophilic gel, malto dextrin and starch. The method is characterized in that: an energy substance is embedded in a network structure formed by the hydrophilic gel, and is stably released from pores of the network, so that the energy is slowly released. The production process is feasible, the raw materials are wide in sources, and the cost is low; in addition, compared with the common sucked jelly, the energy sustained-release sucked jelly has effects of providing the energy substance and slowly releasing energy, and has obvious economical and social benefits.

The invention relates to a hypoglycemic drug composition, which contains alpha-glucosaccharase inhibitor and Indian Trumetflower Seed extract, wherein the Indian Trumetflower Seed extract is prepared by the processes of extracting the Indian Trumetflower Seed with aqueous solution of organic solvent, filtering, re-extracting, separating and drying. The drug composition prepared from the Indian Trumetflower Seed extract and alpha-glucosaccharase inhibitor lower than normal dosage has excellent hypoglycemic effect. The hypoglycemic drug composition has the main advantages that postprandial blood glucose can be reduced faster and more efficiently, and less alpha-glucosaccharase inhibitor is used, so the drug effect can be improved, the toxic and side effects of the alpha-glucosaccharase inhibitor are effectively reduced, and the problems of hypoglycemia and the like easily caused by drug combination are also effectively solved.

The invention discloses a preparation method of low-blood-glucose-index recombination rice, and belongs to the technical field of food. The method comprises the steps that firstly, after starch in analcohol water phase system and lipid are subjected to low-temperature complexing, varying temperature crystallization is performed to obtain low-blood-glucose-index resistant starch, then, the low-blood-glucose-index resistant starch is adopted as a main raw material, the extrusion technology is adopted for preparing the low-blood-glucose-index recombination rice; the low-blood-glucose-index resistance starch prepared through the method has the functions of controlling after-meal blood glucose, protecting and conveying fatty acid, delaying starch aging and the like; the low-blood-glucose-indexrecombination rice obtained through the method is applicable to patients with type 2 diabetes, and has the advantages of increasing the addition value of subsidiary agricultural products, lowering the production cost of the rice, improving the rice production efficiency and the like.

The invention relates to steamed bread for being eaten by patients who suffer from diabetes and a preparation method thereof. The preparation method comprises the following steps of: 1, weighing the following raw materials in part by weight: 15 to 18 parts of finger citron, 20 to 25 parts of medlar, 16 to 19 parts of pumpkin, 10 to 12 parts of kudzuvine root, 5 to 7 parts of coix seed, 10 to 13 parts of Indian buead and 15 to 19 parts of citron fruit; 2, mixing the raw materials, adding water for decocting twice, wherein at the first time, water in an amount which is 10 times that of the mixture is added for decocting for 2 hours, and at the second time, water in an amount which is 8 times that of the mixture is added for decocting for 1.5 hours; filtering decoction extract at two times with a 160 to 180-mesh sieve, and concentrating filter liquor until the density is between 1.23 and 1.26 g / cm<3> to obtain extractum; and mixing the extractum and flour according to a weight ratio of 1:8-12, and preparing the mixture into the steamed bread by the conventional process for preparing the steamed bread. The steamed bread can nourish pancreas islet cells, improve a pancreas islet function, control glucogenic indexes of food effectively, reduce fasting and postprandial blood sugar, reduce the using amount of medicaments for treating the diabetes and improve living quality.

The invention relates to a medicinal composition for treating type II diabetes mellitus and a preparation method thereof. The medicinal composition comprises the following components in part by weight: 10 to 60 parts of astragalus, 10 to 100 parts of glossy ganoderma, 5 to 30 parts of glossy privet fruit and 6 to 30 parts of dark plum fruit. The medicinal composition of the invention can reduce fasting blood glucose and postprandial blood glucose and glycated hemoglobin effectively and relieve inflammation symptoms effectively, and has the good improved effect on the insulin resistance of patients who suffer from the type II diabetes mellitus.

The invention relates to application of total saponins in unripe siraitia grosvenorii fruit extract in preparation of an assistant hypoglycemic drug. Extract containing the total saponins with the content by weight of 60%-90% is extracted from unripe siraitia grosvenorii fruit with the growing period of 30 days-80 days, one of the effective ingredients mogroside II and mogroside III in the total saponins or a mixture of the effective ingredients mogroside II and mogroside III in the total saponins inhibits the activity of alpha-glucosidase in vitro and in vivo, the fasting blood-glucose level and the postprandial blood glucose level of a type-II diabetic mouse are lowered, and the activity of the insulin resistance index is reduced; in addition, new application of the total saponins in preparation of food or the drug for assisting in treating insulin resistance and type-II diabetes mellitus is achieved.

The invention relates to a technique for reducing in-vivo decomposition and absorption speed of starch, which is characterized by comprising the following steps: pulverizing starch food raw materials into fine powder or directly using starch,, adding a thickener and plant extracts, adding water, stirring uniformly to form a soft material, putting in a double screw extruder, extruding with a mold to obtain granules, and drying for later use; or drying the soft material, and pulverizing into fine powder for later use. The technique is characterized in that plant the extracts capable of inhibiting alpha-glucosaccharase and edible thickener are added into the starch to inhibit the alpha-glucosaccharase and reconstruct the physical structure of starch granules, so that the starch decomposition is retarded, and the blood sugar after eating can not increase rapidly but is in a stable state, thereby lowering the postprandial blood sugar, lowering various complications initiated by blood sugar fluctuations after eating, and enhancing the life quality of diabetics.

The invention relates to vigour-consolidating porridge with low glycemic index after dinner and further relates to a factory preparation method of the health-care porridge. The vigour-consolidating porridge with low glycemic index comprises the following solid ingredients and contents: 23.1-38.5 percent of black rice, 27.5-42.9 percent of barley, 6.8 percent of chickpea, 11.9 percent of mung bean, 6.8 percent of soybean, 3.4 percent of red lentil and 5.1 percent of konjac; and liquid ingredient is an oat fiber aqueous solution, in which the proportion of oat fiber to water is 1: 26. According to the vigour-consolidating porridge with low glycemic index, disclosed by the invention, adopts organic raw materials and is prepared by completely using a physical processing method without adding any preservatives, so that all natural nutrients in the raw materials are preserved; in addition, a functional food base material, that is, oat fiber is added in the processing process; the oat fiber can be used for effectively limiting absorption of fat in digestive tracts, promoting excretion of lipid compounds, increasing satiety, reducing food intake and promoting slowing of glucose absorption, so that the blood glucose level after dinner is lowered, the blood lipid is lowered and the obesity is prevented.

The invention discloses a method for preparing a starch-protein complex having digestion resistance and high nutrition, and belongs to the technical field of foods. By combination with protein with starch as a raw material, a protein-starch nutritional strengthening system with anti-digestive characteristics and high nutrition is constructed, and a functional food beneficial to the health of obeseand diabetic people is developed. The preparation method is simple, raw material sources are rich, and complex chemical modification does not need to be used; and the digestibility of the obtained product starch is remarkably lowered, which has a certain control effect on postprandial blood sugar.